https://www.macrotrends.net/stocks/charts/BCRX/biocryst-pharmaceuticals/long-term-debt
BioCryst Pharmaceuticals Long Term Debt 2012-2026 | BCRX | MacroTrends
BioCryst Pharmaceuticals long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
biocryst pharmaceuticalslong termdebt20122026
https://www.kitco.com/markets/stocks/BATS%3ABCRX
BCRX
bcrx
https://www.kitco.com/markets/stocks/SEED_ALEXDRAYM_SHORTINTEREST1%3ABCRX
BCRX
bcrx
https://www.kitco.com/markets/stocks/SEED_OLIMCHIK_QUANT%3ABCRX_UDV
SEED_OLIMCHIK_QUANT:BCRX_UDV
seedquantbcrxudv
https://www.kitco.com/markets/stocks/CAPITALCOM%3ABCRX
BCRX
bcrx
https://www.fool.com/earnings/call-transcripts/2021/11/03/biocryst-pharmaceuticals-bcrx-q3-2021-earnings-cal/
BioCryst Pharmaceuticals (BCRX) Q3 2021 Earnings Call Transcript | The Motley Fool
Nov 3, 2021 - BCRX earnings call for the period ending September 30, 2021.
earnings call transcriptbiocryst pharmaceuticalsthe motleybcrxq3
https://www.kitco.com/markets/stocks/CFI%3ABCRX
BCRX
bcrx
https://www.insidermonkey.com/blog/biocryst-pharmaceuticals-inc-nasdaqbcrx-q1-2024-earnings-call-transcript-1298302/
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript - Insider Monkey
BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23.
biocryst pharmaceuticals incearnings call transcriptq1 2024
https://www.fool.com/earnings/call-transcripts/2024/02/26/biocryst-pharmaceuticals-bcrx-q4-2023-earnings-cal/
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript | The Motley Fool
Feb 26, 2024 - BCRX earnings call for the period ending December 31, 2023.
earnings call transcriptbiocryst pharmaceuticalsq4 2023the motleybcrx
https://www.kitco.com/markets/stocks/FINRA%3ABCRX_SHORT_VOLUME
BCRX_SHORT_VOLUME
bcrxshortvolume
https://www.benzinga.com/news/22/04/26543907/why-biocryst-pharmaceuticals-stock-is-plunging-today
Why BioCryst Pharmaceuticals Stock Is Plunging Today - BioCryst Pharma (NASDAQ:BCRX) - Benzinga
Apr 8, 2022 - BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading significantly lower Friday after the company paused enrollment in clinical trials with BCX9930...
biocryst pharmaceuticalsstock
https://stockhouse.com/companies/profile?symbol=bcrx
NDAQ:BCRX | Company Profile | BioCryst Pharmaceuticals Inc
Get corporate information about BioCryst Pharmaceuticals Inc (NDAQ:BCRX). Includes physical address, website address, emails, CEO info, and industry...
company profilebiocryst pharmaceuticalsndaqbcrxinc
https://www.macrotrends.net/stocks/charts/BCRX/biocryst-pharmaceuticals/operating-margin
BioCryst Pharmaceuticals Operating Margin 2012-2026 | BCRX | MacroTrends
Current and historical operating margin for BioCryst Pharmaceuticals (BCRX) over the last 10 years. The current operating profit margin for BioCryst...
biocryst pharmaceuticalsoperating margin20122026bcrx
https://www.fool.com/earnings/call-transcripts/2019/08/06/biocryst-pharmaceuticals-inc-bcrx-q2-2019-earnings.aspx
Biocryst Pharmaceuticals Inc (BCRX) Q2 2019 Earnings Call Transcript | The Motley Fool
Aug 6, 2019 - BCRX earnings call for the period ending June 30, 2019.
biocryst pharmaceuticals incearnings call transcriptq2 2019
https://www.kitco.com/markets/stocks/SEED_CHARLESYWL_CMIND%3ABCRX
BCRX
bcrx
https://www.macrotrends.net/stocks/charts/BCRX/biocryst-pharmaceuticals/roi
BioCryst Pharmaceuticals Return on Investment 2012-2026 | BCRX | MacroTrends
Current and historical return on investment (ROI) values for BioCryst Pharmaceuticals (BCRX) over the last 10 years.
return on investmentbiocryst pharmaceuticals20122026bcrx
https://www.fxempire.com/stocks/bcrx/earnings
BioCryst Pharmaceuticals Inc (BCRX) Earnings Reports & Dates | FXEmpire
Dive into BioCryst Pharmaceuticals Inc financial stats - earnings and revenue, analyze past reports, compare to industry peers' performance, and stay informed...
biocryst pharmaceuticals incearnings reportsbcrxdates